Approval · Notice of Compliance 1645 · 2004
NU-MEDROXY: Notice of Compliance 1645
Issued April 21, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1645
- Date
- April 21, 2004
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Progestin
- Canadian reference product
- PROVERA (Pharmacia & Upjohn Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-MEDROXY | 02252740 | Cancelled (Unreturned Annual) |
| NU-MEDROXY | 02252759 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- MEDROXYPROGESTERONE ACETATE 2.5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 5 MG per TAB